Version 2.80

Description

Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. ateglinide belongs to the meglitinide class of blood glucose-lowering drugs.

Nateglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the β cells. This depolarizes the β cells and causes voltage-gated calcium channels to open. The resulting calcium influx induces fusion of insulin-containing vesicles with the cell membrane, and insulin secretion occurs. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia , Wikipedia

Basic Part Properties

Part Name
Nateglinide
Part Display Name
Nateglinide
Part Type
Component (Describes the core component or analyte measured)
Created On
2007-06-18
Construct for LOINC Short Name
Nateglinide

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP64443-2
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP64443-2

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 那格列奈
Synonyms: Fastic;Nateglinide;Starlix;Starsis;山之内
es-ES Spanish (Spain) Nateglinida
it-IT Italian (Italy) Nateglinide
et-EE Estonian (Estonia) Nategliniid
tr-TR Turkish (Turkey) Nateglinid
ru-RU Russian (Russian Federation) Натеглинид
fr-BE French (Belgium) Natéglinide
fr-CA French (Canada) Natéglinide
nl-NL Dutch (Netherlands) nateglinide
el-GR Greek (Greece) Νατεγλινίδη
Synonyms: Νατεγλινίδη